Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Ziwei Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya Nursing School, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Sirtuin 1, Pulmonary Fibrosis, Signal Transduction, Oxidative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, China, the Fund for the State Key Laboratory of Hunan Province, China.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis treatments are limited, often with severe side effects, highlighting the need for novel options. Taraxerone has diverse biomedical properties, but its mechanism remains unclear. This study investigates taraxerone's impact and the mechanisms involved in bleomycin‐induced pulmonary fibrosis in mice. After establishing a pulmonary fibrosis mouse model, taraxerone was intraperitoneally injected continuously for 14–28 days. The in vivo antifibrotic and antioxidative stress effects of taraxerone were assessed. In vitro, the influence of taraxerone on transforming growth factor‐β1‐induced myofibroblast transformation and oxidative stress was investigated. Subsequently, quantitative polymerase chain reaction screened the histone deacetylase and Sirtuin family, and taraxerone's effects on SIRT1 were assessed. After SIRT1 siRNA treatment, changes in myofibroblast transformation and antioxidant capacity in response to taraxerone were observed. Acetylation and phosphorylation levels of Smad3 were evaluated. We also examined the binding levels of SIRT1 with Pho‐Smad3 and Smad3, as well as the nuclear localization of Smad2/3. EX527 confirmed SIRT1's in vivo action in response to taraxerone. In vitro experiments suggested that taraxerone inhibited myofibroblast differentiation by activating SIRT1 and reducing oxidative stress. We also observed a new interaction between SIRT1 and the Smad complex. Taraxerone activates SIRT1, enabling it to bind directly to Smad3. This leads to reduced Smad complex phosphorylation and limited nuclear translocation. As a result, the transcription of fibrotic factors is reduced. In vivo validation confirms taraxerone's SIRT1‐mediated antifibrotic effectiveness. This suggests that targeting SIRT1‐mediated inhibition of myofibroblast differentiation could be a key strategy in taraxerone‐based therapy for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya Nursing School, Central South University, Changsha, China.
- Laboratory Medicine Department, Xiangya Hospital, Central South University, Changsha, China.
- Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China.
- National Experimental Teaching Demonstration Center for Medical Function, Central South University, Changsha, China.
ORCID-Profile: Wei Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province, China
- the Fund for the State Key Laboratory of Hunan Province, China
- The open Sharing Fund for the Large-scale Instruments and Equipments of Central South University
- The Science and Technology Innovation Program of Hunan province
- the Fundamental Research Funds for the Central Universities of Central South University
- Natural Science Foundation of Hunan Province
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Chen, Z., Xie, W., Tang, S., Lin, M., Ren, L., Huang, X., Deng, L., Qian, R., Wang, Z., Xiong, D., Xie, P., & Liu, W. (2024). Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner. Phytotherapy Research. https://doi.org/10.1002/ptr.8221
Vancouver
Chen Z, Xie W, Tang S, Lin M, Ren L, Huang X, et al. Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner. Phytotherapy Research. 2024. doi:10.1002/ptr.8221
BibTeX
@article{Chen2024,
author = {Chen, Ziwei and Xie, Weixi and Tang, Siyuan and Lin, Miao and Ren, Lu and Huang, Xiaoting and Deng, Lang and Qian, Rui and Wang, Zun and Xiong, Dayang and Xie, Pingli and Liu, Wei},
title = {Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8221}
}
EUVIMED